News | March 10, 2008

Rush University Medical Center in Training for Temporary Artificial Heart

March 10, 2008 – On March 10 and 11, at Rush University Medical Center (RUSH), Chicago, IL, a mechanical circulatory support and heart transplant team will participate in the first phase of certification training for the CardioWest temporary Total Artificial Heart (TAH-t), which could designate Rush as one of the first U.S. healthcare facilities able to discharge artificial heart patients home for their recovery.

In the first half of 2008, SynCardia Systems, Inc. plans to make an application to the FDA to conduct an IDE clinical study of a universal driver system designed for use in both the hospital and for discharge. The team led by chair of Cardiovascular Thoracic Surgery, Robert S.D. Higgins, M.D., and Cardiologist Jose C. Mendez, M.D., notes that the IDE clinical study still is pending FDA clearance for the Companion Universal Driver. If it is approved, “we will be one of the first centers in the U.S. able to discharge artificial heart patients home for their recovery,” Dr. Higgins said. “We are extremely excited about bringing this life-saving technology to the Chicagoland area for patients battling end stage heart failure. The CardioWest artificial heart provides the best biventricular support available.”

The third phase of CardioWest certification training is the proctored first implant of the artificial heart. Rush will be the 32nd hospital in the world and the 16th in the U.S. to complete the first phase of certification training. There are currently 24 TAH-t certified centers worldwide, with eight additional hospitals currently undergoing the certification process.

For more information: www.syncardia.com

Related Content

St. Jude Medical, HeartMate 3 LVAS, MOMENTUM 3 IDE study results, AHA Scientific Sessions 2016
News | Ventricular Assist Devices (VAD)| December 08, 2016
St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-breaking clinical trial...
SynCardia, Chapter 11 reorganization, sale, Total Artificial Heart
News | Artificial Heart| September 13, 2016
August 29, 2016 — SynCardia Systems, manufacturer of the...
Carmat, bioprosthetic artificial heart, PIVOTAL study, first implantation, heart failure
News | Artificial Heart| September 09, 2016
Carmat announced that the first implantation of its bioprosthetic artificial heart within the framework of the PIVOTAL...
SynCardia acquired, Versa Capital Management, chapter 11
News | Business| July 07, 2016
SynCardia Systems Inc. announced that it has entered into an asset purchase agreement (“APA”) with an affiliate of...
SynCardia Total Artificial Heart, TAH-t, documentary, Retro Reports, The New York Times
News | Artificial Heart| March 24, 2016
March 24, 2016 — A new documentary produced by Retro Report for The New York Times looks at the history and
Bryan Tyo, Baylor University Medical Center, bridge to transplant, Total Artificial Heart
News | Artificial Heart| March 18, 2016
A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient...
HeartWare, ENDURANCE2 trial, destination therapy, HVAS, HeartWare Ventricular Assist System
News | Ventricular Assist Devices (VAD)| August 11, 2015
HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical trial has been...
News | January 30, 2015
SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the...
syncardia, artificial heart

SynCardia Total Artificial Heart

News | November 24, 2014
A 19-year-old woman was successfully implanted with the SynCardia temporary Total Artificial Heart and bridged to a...
Overlay Init